Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Extract of Urtica dioica on Perennial Allergic Rhinitis
IRCT2013102715177N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- May 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of urtica dioica extract in allergic rhinitis (AR), sponsored by Mashhad University of Medical Sciences. Started May 2013; status: completed.
02
Drugs
urtica dioica extract
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on IRCT2013102715177N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013102715177N1.